Fresenius nears definitive deal to divest hemodialysis concentrate plant to Di-Chem under FTC pact.
This article was originally published in The Gray Sheet
Executive Summary
FRESENIUS TO DIVEST HEMODIALYSIS CONCENTRATE PLANT TO DI-CHEM under a consent agreement with the Federal Trade Commission finalized Oct. 15. A definitive agreement for the Fresenius/Di-Chem transaction, for undisclosed terms, was said to be moving toward finalization the week of Nov. 4. The deal was outlined in a letter of intent agreement in May to resolve FTC antitrust concerns stemming from Fresenius' proposed acquisition of W.R. Grace dialysis unit National Medical Care.